CVS Health Corp. (CVS)
Stock Price Chart
Stock Quote
| Trading Day | Apr 9, 2020 |
| Last Price | $60.47 |
| Change ($) | 1.06 |
| Change (%) | 1.78% |
| Previous Close | 59.41 |
| Day's Open | 59.52 (0.19%) |
| Day's Range | 59.32 - 61.45 |
| Day's Volume | 9,161,648 |
| 52-Week Range | 51.72 - 76.44 |
Key Info
| Market Cap | 78.95B |
| Revenue (ttm) | 255.77B |
| Net Income (ttm) | 6.63B |
| Shares Out | 1.31B |
| EPS (ttm) | 5.08 |
| PE Ratio | 11.19 |
| Forward PE | 7.97 |
| Dividend | $2.00 |
| Dividend Yield | 3.31% |
Key Stats and Metrics
| Market Cap | 78.95B |
| Enterprise Value | 159.90B |
| Earnings Date (est) | May 6, 2020 |
| Ex-Dividend Date | Jan 22, 2020 |
| Shares Outstanding | 1.31B |
| Float | 1.30B |
| EPS (basic) | 5.1 |
| EPS (diluted) | 5.08 |
| FCF / Share | 7.99 |
| Dividend | $2.00 |
| Dividend Yield | 3.31% |
| Earnings Yield | 8.40% |
| FCF Yield | 13.16% |
| Payout Ratio | 39.20% |
| Shares Short | 17.67M |
| Short Ratio | 1.17 |
| Short % of Float | 1.36% |
| Beta | 0.77 |
| PE Ratio | 11.19 |
| Forward PE | 7.97 |
| P/FCF Ratio | 7.60 |
| PS Ratio | 0.31 |
| PB Ratio | 1.16 |
| Revenue | 255.77B |
| Operating Income | 11.99B |
| Net Income | 6.63B |
| Free Cash Flow | 10.39B |
| Net Cash | -80.95B |
| Net Cash / Share | -62.00 |
| Gross Margin | 17.41% |
| Operating Margin | 4.69% |
| Profit Margin | 2.60% |
| FCF Margin | 4.06% |
| ROA | 3.53% |
| ROE | 10.81% |
| ROIC | 8.50% |
Stock Analysis Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 256,776 | 194,579 | 184,786 | 177,546 | 153,290 | 139,367 | 126,761 | 123,120 | 107,080 | 95,778 |
| Revenue Growth | 31.96% | 5.3% | 4.08% | 15.82% | 9.99% | 9.94% | 2.96% | 14.98% | 11.8% | - |
| Gross Profit | 45,528 | 31,538 | 28,528 | 28,834 | 26,528 | 25,367 | 23,783 | 22,488 | 20,562 | 20,219 |
| Operating Income | 11,987 | 4,021 | 9,538 | 10,386 | 9,454 | 8,799 | 8,037 | 7,210 | 6,331 | 6,137 |
| Net Income | 6,634 | -594 | 6,622 | 5,317 | 5,237 | 4,644 | 4,592 | 3,864 | 3,462 | 3,427 |
| Shares Outstanding | 1,301 | 1,044 | 1,020 | 1,073 | 1,118 | 1,161 | 1,217 | 1,271 | 1,338 | 1,367 |
| Earnings Per Share | 5.08 | -0.57 | 6.44 | 4.90 | 4.63 | 3.96 | 3.74 | 3.01 | 2.57 | 2.49 |
| EPS Growth | - | - | 31.43% | 5.83% | 16.92% | 5.88% | 24.25% | 17.12% | 3.21% | - |
| Dividend Per Share | 2.00 | 2.00 | 2.00 | 1.70 | 1.40 | 1.10 | 0.90 | 0.65 | 0.50 | 0.35 |
| Dividend Growth | 0% | 0% | 17.65% | 21.43% | 27.27% | 22.22% | 38.46% | 30% | 42.86% | - |
| Operating Cash Flow | 12,848 | 8,865 | 8,007 | 10,141 | 8,539 | 8,137 | 5,783 | 6,671 | 5,856 | 4,779 |
| Capital Expenditures | -2,457 | -2,037 | -1,918 | -2,224 | -2,332 | -2,125 | -1,930 | -2,007 | -1,868 | -1,971 |
| Free Cash Flow | 10,391 | 6,828 | 6,089 | 7,917 | 6,207 | 6,012 | 3,853 | 4,664 | 3,988 | 2,808 |
| Cash & Equivalents | 25,370 | 22,313 | 1,919 | 3,458 | 2,547 | 2,515 | 4,177 | 1,380 | 1,418 | 1,431 |
| Total Debt | 89,002 | 73,429 | 27,002 | 27,531 | 27,464 | 12,890 | 13,402 | 9,828 | 10,014 | 10,057 |
| Net Cash / Debt | -63,632 | -51,116 | -25,083 | -24,073 | -24,917 | -10,375 | -9,225 | -8,448 | -8,596 | -8,626 |
| Assets | 222,449 | 196,456 | 95,131 | 94,462 | 92,437 | 74,187 | 71,526 | 66,221 | 64,543 | 62,169 |
| Liabilities | 158,279 | 137,913 | 57,436 | 57,628 | 55,234 | 36,224 | 33,588 | 28,568 | 26,492 | 24,469 |
| Book Value | 63,864 | 58,225 | 37,691 | 36,830 | 37,196 | 37,958 | 37,938 | 37,653 | 38,051 | 37,700 |
Company Profile
Company Details
| Full Name | CVS Health Corp. |
| Home Country | United States |
| Employees | 290,000 |
| CEO | Larry J. Merlo |
Stock Information
| Ticker symbol | CVS |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Healthcare Plans |
Description
CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans (PDPs), Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail order, mail order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. Its Retail/LTC segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. As of December 31, 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. The company was founded in 1963 and is headquartered in Woonsocket, Rhode Island.